Scoop: Just months after Sanofi AI deal, Atomwise laid off 30% of staffers amid 'strategic shift'
Atomwise, a well-connected player in the burgeoning space of artificial intelligence-powered drug discovery, cut its headcount by 30% in December, Endpoints News has learned. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.